Diagnostic Performance of Positron Emission Tomography with Fibroblast-Activating Protein Inhibitors in Gastric Cancer: A Systematic Review and Meta-Analysis

Alessio Rizzo1, Manuela Racca1, Federico Garrou2, Elisabetta Fenocchio3, Luca Pellegrino4, Domenico Albano5, Francesco Dondi5, Francesco […]

2025-10-15T16:39:33+00:0029, Aug 2023|Publications|

Fibroblast Activation Protein (FAP) – a target for Imaging and Therapy

Presented by: Sherly Mosessian, PhD, SOFIE Chief Scientific Officer
Targeted Radiopharmaceuticals Summit US (TRP) – Boston, […]

2025-11-03T16:06:22+00:0025, Jul 2023|Presentations|

FAP symposium another success at 2023 SNMMI meeting

June 25, 2023 – For the second year in a row, the spotlight shone on […]

2025-10-15T16:42:11+00:007, Jul 2023|News|

SOFIE FAPI diagnostic-clinical development updates

Presented by: Sherly Mosessian, PhD, SOFIE Chief Scientific Officer
2023 Annual SNMMI Meeting – Chicago, Illinois
June […]

2025-11-03T16:08:36+00:0025, Jun 2023|Presentations|

FAP Radioligands for Imaging and Therapy

Watch Webinar

2026-05-10T01:14:05+00:0024, Jun 2023|Presentations|

RLS and SOFIE Enter Strategic Partnership for Distribution of Nuclear Medicine Doses for Patients

LAKE ZURICH, Il. and DULLES, Va. — June 21, 2023, RLS (USA), […]

2025-10-13T13:46:01+00:0021, Jun 2023|News|

Current State of FAP Ligands for Diagnostic Use in Oncology

Presented by: Sherly Mosessian, PhD, SOFIE Chief Scientific Officer
June 14, 2023 Download the Presentation […]

2025-11-04T00:37:10+00:0014, Jun 2023|Presentations|

Focus on FAPI Newsletter – Q2 2023

A WORD FROM OUR CHIEF SCIENTIFIC OFFICER

Dear FAPI community,

This quarter, the FAPI team celebrated […]

2025-12-03T20:03:58+00:0012, Jun 2023|Newsletter|

SOFIE partners with BAMF Health, diversifying sites for Phase II [68Ga]FAPI-46 study

SOFIE has added BAMF Health, a novel cancer treatment center in Grand Rapids, Michigan, as […]

2025-10-15T16:42:11+00:006, Jun 2023|News|

First Patient Imaged in SOFIE’s 18F-FAPI Phase 2 trial

Dulles, VA –May 12, 2023 – SOFIE Biosciences (SOFIE), an established US manufacturer and developer […]

2025-10-15T16:42:14+00:0012, May 2023|News|
Go to Top